Literature DB >> 11566484

Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells.

A Goel1, C R Boland, D P Chauhan.   

Abstract

Curcumin, a major yellow pigment and active component of turmeric, has been shown to possess anti-inflammatory and anti-cancer activities. Cyclooxygenase (COX)-2 plays an important role in colon carcinogenesis. To investigate the effect of curcumin on COX-2 expression, we treated HT-29 human colon cancer cells with various concentrations of curcumin. Curcumin inhibited the cell growth of HT-29 cells in a concentration- and time-dependent manner. Curcumin markedly inhibited the mRNA and protein expression of COX-2, but not COX-1. These data suggest that a non-toxic concentration of curcumin has a significant effect on the in vitro growth of HT-29 cells, specifically inhibits COX-2 expression, and may have value as a safe chemopreventive agent for colon cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566484     DOI: 10.1016/s0304-3835(01)00655-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  74 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin.

Authors:  Markus Griesser; Valentina Pistis; Takashi Suzuki; Noemi Tejera; Derek A Pratt; Claus Schneider
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

3.  Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.

Authors:  John E Eaton; Kevin M Nelson; Andrea A Gossard; Elizabeth J Carey; James H Tabibian; Keith D Lindor; Nicholas F LaRusso
Journal:  Scand J Gastroenterol       Date:  2019-05-26       Impact factor: 2.423

4.  Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats.

Authors:  Ilan Aroch; Sarah Kraus; Inna Naumov; Ehud Ron; Shiran Shapira; Dina Kazanov; Nis Giladi; Alex Litvak; Shahar Lev-Ari; Aharon Hallak; Iris Dotan; Baruch Shpitz; Nadir Arber
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

5.  Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.

Authors:  Jyoti Nautiyal; Sanjeev Banerjee; Shailender S Kanwar; Yingjie Yu; Bhaumik B Patel; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

6.  Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.

Authors:  Vesna Milacic; Sanjeev Banerjee; Kristin R Landis-Piwowar; Fazlul H Sarkar; Adhip P N Majumdar; Q Ping Dou
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 7.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

8.  In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.

Authors:  Heba Mohamed Fahmy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-03       Impact factor: 3.000

Review 9.  Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways.

Authors:  Satya Narayan
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step.

Authors:  John W A Rossen; Janneke Bouma; Rolien H C Raatgeep; Hans A Büller; Alexandra W C Einerhand
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.